MXPA03010181A - Polipeptidos de citocinas. - Google Patents
Polipeptidos de citocinas.Info
- Publication number
- MXPA03010181A MXPA03010181A MXPA03010181A MXPA03010181A MXPA03010181A MX PA03010181 A MXPA03010181 A MX PA03010181A MX PA03010181 A MXPA03010181 A MX PA03010181A MX PA03010181 A MXPA03010181 A MX PA03010181A MX PA03010181 A MXPA03010181 A MX PA03010181A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- polypeptides
- imx129840
- cytokine
- cytokine polypeptides
- Prior art date
Links
- 102000004127 Cytokines Human genes 0.000 title abstract 4
- 108090000695 Cytokines Proteins 0.000 title abstract 4
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000001778 pluripotent stem cell Anatomy 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29023901P | 2001-05-10 | 2001-05-10 | |
| PCT/US2002/014587 WO2002092762A2 (en) | 2001-05-10 | 2002-05-08 | Cytokine polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03010181A true MXPA03010181A (es) | 2004-03-16 |
Family
ID=23115104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03010181A MXPA03010181A (es) | 2001-05-10 | 2002-05-08 | Polipeptidos de citocinas. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20030104579A1 (https=) |
| EP (1) | EP1412499A4 (https=) |
| JP (1) | JP2004535795A (https=) |
| AU (1) | AU2002314774B2 (https=) |
| CA (1) | CA2446180A1 (https=) |
| MX (1) | MXPA03010181A (https=) |
| PL (1) | PL373008A1 (https=) |
| WO (1) | WO2002092762A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60135393D1 (de) | 2000-06-30 | 2008-09-25 | Zymogenetics Inc | Allelische Variante des Interferon-ähnlichen Proteins Zcyto21 |
| US7038032B2 (en) | 2001-04-20 | 2006-05-02 | Zymogenetics, Inc. | Cytokine protein family |
| US7910313B2 (en) | 2001-04-20 | 2011-03-22 | Zymogenetics, Inc. | Cytokine protein family |
| EP1942187B1 (en) * | 2001-04-20 | 2010-09-22 | ZymoGenetics, L.L.C. | Cytokine protein family |
| WO2003066002A2 (en) | 2002-02-08 | 2003-08-14 | University Of Medicine And Dentistry Of New Jersey | IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION |
| CA2503305A1 (en) | 2002-10-23 | 2004-05-06 | Zymogenetics, Inc. | Methods for treating viral infection using il-28 and il-29 |
| EP2251352A1 (en) * | 2003-08-07 | 2010-11-17 | ZymoGenetics, L.L.C. | Homogeneous preparations of IL-28 and IL-29 |
| JP4896005B2 (ja) | 2004-04-02 | 2012-03-14 | ザイモジェネティクス リミテッド ライアビリティ カンパニー | Ｉｌ−２８およびｉｌ−２９システイン変異体を用いるウイルス感染を治療するための方法 |
| JP2008508310A (ja) | 2004-07-29 | 2008-03-21 | ザイモジェネティクス， インコーポレイテッド | がんおよび自己免疫障害を治療するためのｉｌ−２８およびｉｌ−２９の使用法 |
| US8158129B2 (en) * | 2005-04-06 | 2012-04-17 | Ibc Pharmaceuticals, Inc. | Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo |
| AU2006272937A1 (en) * | 2005-07-20 | 2007-02-01 | Bristol-Myers Squibb Company | Use of truncated cysteine IL28 and IL29 mutants to treat cancers and autoimmune disorders |
| CA2891974A1 (en) | 2012-11-21 | 2014-05-30 | The Governors Of The University Of Alberta | Immunomodulatory peptides and methods of use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60135393D1 (de) * | 2000-06-30 | 2008-09-25 | Zymogenetics Inc | Allelische Variante des Interferon-ähnlichen Proteins Zcyto21 |
| US6822082B2 (en) * | 2000-06-30 | 2004-11-23 | Zymogenetics, Inc. | Polynucleotides for mammalian secreted protein, Z1055G2P |
-
2002
- 2002-05-08 WO PCT/US2002/014587 patent/WO2002092762A2/en not_active Ceased
- 2002-05-08 PL PL02373008A patent/PL373008A1/xx not_active Application Discontinuation
- 2002-05-08 MX MXPA03010181A patent/MXPA03010181A/es unknown
- 2002-05-08 EP EP02741697A patent/EP1412499A4/en not_active Withdrawn
- 2002-05-08 JP JP2002589630A patent/JP2004535795A/ja not_active Withdrawn
- 2002-05-08 CA CA002446180A patent/CA2446180A1/en not_active Abandoned
- 2002-05-08 US US10/142,717 patent/US20030104579A1/en not_active Abandoned
- 2002-05-08 AU AU2002314774A patent/AU2002314774B2/en not_active Ceased
-
2006
- 2006-11-20 US US11/602,056 patent/US20070081973A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20070081973A1 (en) | 2007-04-12 |
| WO2002092762A2 (en) | 2002-11-21 |
| WO2002092762A3 (en) | 2004-03-04 |
| AU2002314774B2 (en) | 2007-06-28 |
| EP1412499A2 (en) | 2004-04-28 |
| US20030104579A1 (en) | 2003-06-05 |
| CA2446180A1 (en) | 2002-11-21 |
| JP2004535795A (ja) | 2004-12-02 |
| EP1412499A4 (en) | 2005-04-06 |
| PL373008A1 (en) | 2005-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03010181A (es) | Polipeptidos de citocinas. | |
| ATE286053T1 (de) | Naphthyridinone zur hemmung der durch protein- tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung | |
| DE69725587D1 (de) | Verwendung von wnt polypeptiden | |
| WO2002102997A3 (en) | Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same | |
| EP1272506A4 (en) | HUMAN AMINOACYL-ARNT SYNTHETASE POLYPEPTIDES USEFUL FOR REGULATING ANGIOGENESIS | |
| SG152273A1 (en) | Pdx1 expressing endoderm | |
| WO2005020921A3 (en) | C-kit modulators and methods of use | |
| MY125594A (en) | Immortalized cell lines for virus growth | |
| GB2394723A (en) | Culture system for rapid expansion of human embryonic stem cells | |
| AU2000233235A1 (en) | Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase | |
| WO2003060082A3 (en) | Use of modified pyrimidine compounds to promote stem cell migration and proliferation | |
| WO2004015077A3 (en) | Compositions and methods for neural differentiation of embryonic stem cells | |
| EP0559769A4 (en) | Heparin binding mitogen with homology to epidermal growth factor (egf) | |
| ATE462782T1 (de) | Endothelstammzellen, populationen, isolierungsverfahren und verwendung davon | |
| MXPA04004266A (es) | Uso de il-19, il-22 e il-24 para tratar trastornos hematopoyeticos. | |
| MXPA03001468A (es) | Polipeptidos de claudia. | |
| WO2003010291A3 (en) | Treatment of immune disorders and b cell disorders | |
| Fuchigami et al. | Fibroblasts promote the collective invasion of ameloblastoma tumor cells in a 3D coculture model | |
| MXPA03008039A (es) | Polipeptidos de serpina humanos. | |
| WO2021041592A8 (en) | Methods of treating vascular diseases | |
| WO2003095614A3 (en) | Cytokine polypeptides | |
| MY207075A (en) | Human alpha-galactosidase variants | |
| TW200519209A (en) | Culture system and method for expansion and undifferentiated growth of human embryonic stem cells | |
| Tan et al. | Mesenchymal stem cells attract endothelial progenitor cells via a positive feedback loop between CXCR2 and CXCR4 | |
| WO2003029426A3 (en) | Human and murine cytokine polypeptides |